
With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have any hidden therapeutic benefits that could warrant putting additional indications on the label and increase production.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/n5_n5PAFfY8/141125111824.htm